Metabolic pathways are sequences of enzyme-catalyzed chemical reactions that occur within a cell. These pathways convert substrates into products, generate energy, and synthesize the building blocks needed for cellular growth and maintenance.
Types of Metabolic Pathways
Catabolism
Catabolic pathways break down large molecules into smaller ones, releasing energy. The breakdown of glucose through glycolysis and the citric acid cycle is a classic example. The energy released is captured in the form of ATP and reduced electron carriers such as NADH and FADH2.
Anabolism
Anabolic pathways use energy to build complex molecules from simpler ones. Examples include the synthesis of proteins from amino acids, nucleic acids from nucleotides, and fatty acids from acetyl-CoA. These pathways require the input of ATP and reducing power from NADPH.
Amphibolic Pathways
Some pathways serve both catabolic and anabolic functions. The citric acid cycle, for example, oxidizes acetyl-CoA to generate energy while also providing intermediates for amino acid and nucleotide synthesis.
Key Features of Metabolic Pathways
Enzyme Regulation
Pathways are tightly regulated to meet the cell’s needs. Key enzymes are controlled through feedback inhibition, allosteric regulation, and covalent modification. The rate-limiting enzyme of a pathway is usually the first committed step.
Compartmentalization
In eukaryotic cells, metabolic pathways are often compartmentalized in specific organelles. Glycolysis occurs in the cytoplasm, the citric acid cycle in the mitochondria, and fatty acid synthesis in the cytoplasm. This separation allows for independent regulation.
Energy Currency
ATP is the universal energy currency of the cell. NADH and FADH2 carry electrons for oxidative phosphorylation, while NADPH provides reducing power for biosynthetic reactions. The balance of these molecules determines the metabolic state of the cell.
Practical Pathway Mapping and Tracer Studies
Map metabolic pathways using KEGG Mapper (www.kegg.jp/kegg/mapper.html) — enter a list of enzyme Commission numbers or gene identifiers to visualize which pathways are enriched in your dataset. For bacteria, the BioCyc database provides genome-scale pathway mappings. For tracer studies with ¹³C-labeled substrates, culture cells in medium containing [U-¹³C]glucose (25 mM) or [U-¹³C]glutamine (4 mM) for 6–24 hours. Quench metabolism by aspirating medium and adding ice-cold 80% methanol. Extract polar metabolites as described for TCA cycle analysis and analyze by GC-MS or LC-MS. Key labeling patterns: M+3 citrate from [U-¹³C]glucose indicates that glucose-derived pyruvate enters the TCA cycle via pyruvate dehydrogenase; M+4 citrate indicates entry via pyruvate carboxylase (anaplerosis). The ratio of M+2 to M+3 succinate reveals the relative contribution of the forward TCA cycle versus the reverse reductive carboxylation pathway. For flux through the pentose phosphate pathway, measure the labeling of ribose-5-phosphate (M+5 from [1,2-¹³C]glucose) and the release of ¹³CO2 from [1-¹³C]glucose compared to [6-¹³C]glucose — a higher rate from the C1 position indicates PPP activity. Use flux balance analysis software (e.g., OpenFLUX, Metran) to calculate metabolic fluxes by fitting labeling data to a stoichiometric model of central carbon metabolism.
Real-World Application
In a study of cancer metabolism in glioblastoma tumorspheres, [U-¹³C]glucose tracing reveals that 65% of TCA cycle citrate is derived from glucose (M+2 labeling) while 35% comes from glutamine (M+4 labeling). Inhibition of glutaminase with CB-839 reduces the glutamine contribution to 15%, demonstrating metabolic plasticity and identifying a potential therapeutic vulnerability in glutamine-addicted cancers.
